Journal of Clinical Microbiology · 2010 · 72 citations · 6 references
MedicineOncologyPathologyCancer ScreeningDiagnostic MicrobiologyMolecular DiagnosticsCervical CancerCervical CytologyCervical DysplasiaCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyCervical Cancer ScreeningCervical Intraepithelial Neoplasia DiagnosisCervical Precancer DetectionE6 ExpressionE6 OncoproteinFeasibility Study DesignHpv ScreeningHuman Papillomavirus Screening
In a feasibility study using a prototype, lateral-flow test for human papillomavirus type 16, 18, and/or 45 (HPV16/18/45) E6 oncoproteins, 51 of 75 (68%; 95% confidence interval [95% CI] of 56 to 78%) of HPV16/18/45 DNA-positive specimens from women with a diagnosis of CIN3+ (cervical intraepithelial neoplasia grade 3+ or cervical cancer) tested positive for HPV16/18/45 E6 oncoprotein. None of 16 (95% CI of 0 to 37%) HPV16/18/45 DNA-positive cervical specimens from women with a negative or CIN1 diagnosis tested positive for HPV16/18/45 E6 oncoprotein.
6
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan, Bhagwan M. Nene, Surendra S. Shastri et al. · New England Journal of Medicine · 2009 · 1.3K citations